Interleukin-2 injections produce sustained increases in CD4+ T cell counts in early-stage HIV disease.
D018791:CD4 Lymphocyte Count / Q000187:drug effects*; D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000627:therapeutic use*; D013997:Time Factors
D007376:Interleukin-2